---
title: Early phase II data cuts suggest Apreaâ€™s APR-246 will be a game-changer for
  TP53 mutant MDS
image: images/writing/post-52.jpg
link: https://www.clinicaltrialsarena.com/comment/early-phase-ii-data-cuts-suggest-apreas-apr-246-will-be-a-game-changer-for-tp53-mutant-mds/
categories:
- Conference Review
date: 12/18/19
order: '5'

---
